Back to search

France· FR:65639871

ORKAMBI 100 mg/125 mg, granulés en sachet

A ivacaftor and lumacaftor product containing lumacaftor + ivacaftor, registered in France by VERTEX PHARMACEUTICALS (IRELAND), on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC R07AX30

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedORKAMBI 100 mg/125 mg, granulés en sa…ATCR07AX30REGISTER NO.FR:65639871PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Ivacaftor and lumacaftor is registered in 16 of 19 countries.

Countries holding a registration under ATC R07AX30 (ivacaftor and lumacaftor), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 11 of them publish a price we can compare per daily dose

Ivacaftor and lumacaftor · ATC R07AX30

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
LUMACAFTOR + IVACAFTOR
Manufacturer
VERTEX PHARMACEUTICALS (IRELAND)
Country
France (FR)
ATC code
R07AX30
ATC class
Ivacaftor and lumacaftor
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930167441
    56 sachet(s) BoPET : polyéthylène téréphtalate biaxialement orienté polyéthylène aluminium
    EUR 10.1

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a9fd6fd4-c433-4a7d-968f-173f75e37ff0
GET /v1/drugs/a9fd6fd4-c433-4a7d-968f-173f75e37ff0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65639871",
  "date_amm": "2019-01-15",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/15/1059",
  "substance": "LUMACAFTOR + IVACAFTOR",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "granulés",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about ivacaftor and lumacaftor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.